Nouveau BioSciences Leadership

• An unparalleled team of world-renowned translational scientists and physician-scientists from academia and industry with a proven track record, boasting over 12 different FDA drug approvals, including ones with IP held by Founders.

​

• Executive leadership with decades of experience in the biotechnology and pharmaceutical industry sector with global regulatory expertise. 

​​

• Leadership has secured non-dilutive angel funding supporting the discovery, synthesis and pre-clinical evaluation of novel nanomedicine assets.

​​

• A corporate model that leverages a longstanding relationship with one of the top NCI-designated Comprehensive Cancer Centers in the U.S.